Harvard Bioscience
HBIO
HBIO
87 hedge funds and large institutions have $82.3M invested in Harvard Bioscience in 2020 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
5.43% more ownership
Funds ownership: 63.79% → 69.21% (+5.4%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
87
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$5.11M | |
| 2 | +$3.15M | |
| 3 | +$2.54M | |
| 4 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
+$1.8M |
| 5 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$1.28M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$2.74M | |
| 3 | -$1.5M | |
| 4 |
ICM
Invenomic Capital Management
Boston,
Massachusetts
|
-$1.09M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$350K |